Horm Metab Res 1998; 30(2): 61-65
DOI: 10.1055/s-2007-978835
Originals Basic

© Georg Thieme Verlag Stuttgart · New York

Enhancement of Apoptotic Susceptibility in Human Endometrial Epithelial Cell Line HHUA by Transforming Growth Factor-β1

T. Tanaka1 , N. Umesaki1 , K. Mizuno1 , L. Chang1 , M. Miyama1 , S. Ohtaki2 , S. Ogita1
  • 1Department of Obstetrics and Gynecology, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545, Japan
  • 2Department of Laboratory Medicine, Miyazaki Medical College, Kihara 5200, Kiyotake-cho, Miyazaki 889-16, Japan
Weitere Informationen

Publikationsverlauf

1997

1997

Publikationsdatum:
20. April 2007 (online)

Abstract

Although reports have been published on the generation of transforming growth factor-β1 (TCF-β1) and expression of TGF-β receptors in human endometrial tissues, the biological functions of endometrial TGF-β1 have remained unclear. In this study, the effects of TGF-β1 on endometrial apoptosis were examined by using an endometrial epithelial cell line HHUA which is susceptible to Fas-mediated apoptosis. TGF-β1 alone did not affect the cell growth of HHUA, but pretreatment of HHUA with TGF-β1 enhanced Fas-mediated growth suppression and DNA fragmentation of the cells. Flow cytometric analyses showed that TGF-β1 did not affect Fas expression on the cell surface. These findings lead to the conclusion that TGF-β1 enhances susceptibility to Fas-mediated apoptosis in the endometrial epithelial cell. Modulation of Fas-mediated endometrial apoptosis by TGF-β1 may thus be a tissue-specific effect which is distinct from other TGF-β1 effects on Fas-mediated apoptosis in activated T-cells and rheumatoid synovial cells. The biological functions of endometrial TGF-β1 and endometrial apoptosis are also discussed.

    >